Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers.

Adv Radiat Oncol · 2018 · PMC5856978 · PMID 29556579

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantP = .058so close (0.05 < p ≤ 0.1)

18 , 19 , 20 , 21 , 22 , 23 Study results from trial A demonstrated that having a family history of PDAC specifically resulted in a borderline significant improvement in OS (164.4 vs 28.7 months, P = .058).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.